LONDON, 4 July, 2012 – Panmure Gordon & Co, a leading independent institutional stockbroker and investment bank, is pleased to advise that it has acted as sole bookrunner on the IPO of Revolymer plc (REVO.L), conditionally raising £25m. This is the third IPO Panmure Gordon has brought to AIM in as many months. The company’s expected AIM admission date is 10 July with a market capitalisation, based on the placing price, of approximately £53m.

Deeside-based Revolymer is a rapidly growing technology development company which formulates novel polymers that can be added to a wide range of fast moving consumer goods (FMCG), including chewing gums, household products, personal care and coatings & adhesives. Revolymer’s initial commercial product is REV7, a removable and degradable chewing gum, sold in over 3,500 stores in the USA and a similar product is expected to be launched in the UK, Germany and Ireland this year. Revolymer also expect to announce the grant of commercialisation licenses of its technology to larger third parties in the medium term.

Panmure Gordon chief executive, Phillip Wale, commented: “Markets remain exceptionally difficult but we are delighted that Revolymer is the third innovative company we have brought to AIM since May.”

Chairman of investment banking at Panmure Gordon, Tim Linacre, commented: “AIM remains open for business. Companies with excellent business models, a compelling story and strong management teams are able to attract outstanding institutional investors, as has been proven by Revolymer’s successful IPO today and in the IPOs of Snoozebox Holdings plc and WANdisco plc in the previous two months. Each of these IPOs were very well supported, attracting high quality institutional investors.”